414 filings
8-K
XCUR
Exicure Inc
22 Apr 24
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-K
4:20pm
NT 10-K
XCUR
Exicure Inc
1 Apr 24
Notice of late annual filing
4:20pm
4
Josh Miller
6 Mar 24
EXICURE / Josh Miller ownership change
12:15pm
4
DGP Co., Ltd.
4 Mar 24
Change in insider ownership
6:36pm
SC 13D/A
CBI USA, Inc.
4 Mar 24
EXICURE / CBI USA ownership change
5:37pm
8-K
b4pgtv9oncofpumya2
5 Feb 24
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
4:16pm
8-K
prcwzlk sgg87
16 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
4
c8v87l 6r
1 Dec 23
EXICURE / Josh Miller ownership change
6:14pm
8-K
b8ymk818djdc19f9k3
1 Dec 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:21pm
8-K
fawka zs7f7z
28 Nov 23
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q
4:19pm
NT 10-Q
dkuvdvvla vd
14 Nov 23
Notice of late quarterly filing
4:28pm
8-K
xzdo0sntueayz3woc
6 Oct 23
Other Events
5:03pm
3
s332dolr43z49q9y8oj
29 Sep 23
EXICURE / Minhee Eom ownership change
5:05pm
8-K
jqgkw hhzc9at
27 Sep 23
Departure of Directors or Certain Officers
5:25pm
8-K
75l 6hxnno
13 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:03pm
3
1jw0 luaj6y
31 Aug 23
EXICURE / Hyuk Joon Ko ownership change
1:33pm
3
agy5yg5i6c
31 Aug 23
EXICURE / Dongho Lee ownership change
1:33pm
3
014t7rpwrwnc0lxi d6
31 Aug 23
EXICURE / Hojoon Lee ownership change
1:32pm
8-K
hnriy0xe9itbmviy
23 Aug 23
Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
9:29am
4
z9zwuoair tz
18 Aug 23
EXICURE / Josh Miller ownership change
6:09pm